Prime Medicine (PRME) Interest Coverage Ratio: History & Chart

Prime Medicine, Inc.(PRME)

Biotechnology · Cambridge, MA

$3.47+0.26 (+8.10%)

Delayed quote: Oct 6, 2026, 12:50 PM EDT

About Prime Medicine, Inc.

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.

Cambridge, MA

146 employees

www.primemedicine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Allan Reine

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Prime Medicine, Inc. (PRME)	$626.74M	N/A	N/A	N/A	N/A
Climb Bio, Inc. (CLYM)vs ›	$629.66M	N/A	N/A	N/A	N/A
Aura Biosciences, Inc. (AURA)vs ›	$632.00M	N/A	N/A	N/A	N/A
SOPHiA GENETICS S.A. (SOPH)vs ›	$634.70M	-15.57x	N/A	N/A	N/A
OmniAb, Inc. (OABI)vs ›	$651.65M	N/A	N/A	N/A	N/A
AngioDynamics, Inc. (ANGO)vs ›	$597.05M	-133.54x	0.30x	1.45x	7.08x
Ironwood Pharmaceuticals, Inc. (IRWD)vs ›	$598.37M	3.63x	3.22x	13.13x	10.34x
Starling Oncology, Inc. (STLN)vs ›	$661.54M	-3.20x	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$589.36M	-1214.61x	176.24x	176.24x	176.24x
OrthoPediatrics Corp. (KIDS)vs ›	$589.21M	-4.84x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Prime Medicine, Inc. (PRME)

$626.74M

N/A

Climb Bio, Inc. (CLYM)vs ›

$629.66M

N/A

Aura Biosciences, Inc. (AURA)vs ›

$632.00M